Fjarde Ap Fonden Baxter International Inc Transaction History

Fjarde Ap Fonden

$10.8 Billion
Q2 2025

A detailed history of Fjarde Ap Fonden transactions in Baxter International Inc stock. As of the latest transaction made, Fjarde Ap Fonden holds 57,934 shares of BAX stock, worth $1.38 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

57,934

Previous 51,534 12.42%

Holding current value

$1.38 Million

Previous $1.76 Million 0.57%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	BUY	$27.8 - $34.02 $177,920 - $217,728	6,400 Added 12.42%	57,934 $1.75 Million
Q1 2025 May 13, 2025	SELL	$29.26 - $36.57 $441,826 - $552,207	-15,100 Reduced 22.66%	51,534 $1.76 Million
Q4 2024 Feb 04, 2025	BUY	$28.63 - $37.84 $503,888 - $665,984	17,600 Added 35.89%	66,634 $1.94 Million
Q3 2024 Nov 08, 2024	SELL	$32.85 - $40.26 $851,669 - $1.04 Million	-25,926 Reduced 34.59%	49,034 $1.86 Million
Q1 2024 Apr 25, 2024	SELL	$37.88 - $43.77 $147,732 - $170,703	-3,900 Reduced 4.95%	74,960 $3.2 Million
Q3 2023 Oct 23, 2023	SELL	$37.32 - $49.29 $317,220 - $418,965	-8,500 Reduced 9.73%	78,860 $2.98 Million
Q2 2023 Aug 02, 2023	BUY	$39.98 - $47.68 $1.52 Million - $1.81 Million	37,900 Added 76.63%	87,360 $3.98 Million
Q1 2023 May 15, 2023	SELL	$37.58 - $52.57 $496,056 - $693,924	-13,200 Reduced 21.07%	49,460 $2.01 Million
Q4 2022 Feb 14, 2023	SELL	$49.7 - $57.71 $2.63 Million - $3.05 Million	-52,919 Reduced 45.79%	62,660 $3.19 Million
Q2 2022 Aug 11, 2022	BUY	$63.83 - $80.0 $2.92 Million - $3.66 Million	45,700 Added 65.4%	115,579 $7.42 Million
Q1 2022 May 13, 2022	SELL	$76.85 - $89.45 $3.19 Million - $3.72 Million	-41,540 Reduced 37.28%	69,879 $5.42 Million
Q4 2021 Feb 15, 2022	SELL	$74.57 - $87.19 $1.13 Million - $1.32 Million	-15,144 Reduced 11.97%	111,419 $9.56 Million
Q3 2021 Nov 15, 2021	SELL	$73.77 - $83.61 $885,240 - $1 Million	-12,000 Reduced 8.66%	126,563 $10.2 Million
Q2 2021 Aug 12, 2021	SELL	$80.5 - $88.01 $652,050 - $712,881	-8,100 Reduced 5.52%	138,563 $11.2 Million
Q1 2021 May 17, 2021	SELL	$76.38 - $86.03 $175,674 - $197,869	-2,300 Reduced 1.54%	146,663 $12.4 Million
Q4 2020 Feb 12, 2021	BUY	$75.39 - $82.36 $4.33 Million - $4.73 Million	57,400 Added 62.69%	148,963 $12 Million
Q3 2020 Nov 13, 2020	BUY	$78.33 - $90.73 $454,314 - $526,234	5,800 Added 6.76%	91,563 $7.36 Million
Q2 2020 Aug 13, 2020	BUY	$78.66 - $94.14 $983,250 - $1.18 Million	12,500 Added 17.06%	85,763 $7.38 Million
Q1 2020 May 11, 2020	SELL	$71.57 - $93.3 $780,112 - $1.02 Million	-10,900 Reduced 12.95%	73,263 $5.95 Million
Q4 2019 Feb 10, 2020	SELL	$76.7 - $88.45 $5.18 Million - $5.97 Million	-67,498 Reduced 44.51%	84,163 $7.04 Million
Q3 2019 Oct 31, 2019	BUY	$81.4 - $89.78 $367,683 - $405,536	4,517 Added 3.07%	151,661 $13.3 Million
Q2 2019 Jul 17, 2019	SELL	$73.44 - $82.41 $359,856 - $403,809	-4,900 Reduced 3.22%	147,144 $12.1 Million
Q1 2019 Apr 29, 2019	BUY	$64.48 - $81.31 $2.5 Million - $3.15 Million	38,706 Added 34.15%	152,044 $12.4 Million
Q4 2018 Jan 31, 2019	SELL	$61.45 - $77.8 $1.62 Million - $2.05 Million	-26,300 Reduced 18.83%	113,338 $7.46 Million
Q3 2018 Nov 09, 2018	SELL	$70.71 - $77.75 $418,461 - $460,124	-5,918 Reduced 4.07%	139,638 $10.8 Million
Q2 2018 Jul 12, 2018	BUY	$63.43 - $75.41 $596,115 - $708,703	9,398 Added 6.9%	145,556 $10.7 Million
Q1 2018 May 07, 2018	BUY	$62.56 - $72.26 $61,934 - $71,537	990 Added 0.73%	136,158 $8.86 Million
Q4 2017 Feb 12, 2018	BUY	$61.45 - $66.05 $1.06 Million - $1.14 Million	17,328 Added 14.7%	135,168 $8.74 Million
Q3 2017 Nov 07, 2017	BUY	$59.5 - $64.61 $201,526 - $218,834	3,387 Added 2.96%	117,840 $7.39 Million
Q2 2017 Aug 08, 2017	BUY	N/A	114,453	114,453 $6.93 Million

Others Institutions Holding BAX

# of Institutions

913

Shares Held

480M

Call Options Held

3.64M

Put Options Held

1.52M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $12B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account